Abstract:Cancer is one of the leading public health concerns globally; therefore it is required better drugs for treatment. Several strategies have been taken to improve the success of drug discovery. Our strategy is the exploration of organometallic platinum group metal complexes as potential anticancer drugs. Organometallic complexes bearing N-heterocyclic carbene (NHC) ligands are getting attention for therapeutic purposes. Synthesis, structure, and anticancer activities of platinum(II)- and gold(III)-N-heterocyclic carbene complexes supported by proligand 1-methyl-2-(pyridylmethyl)imidazo[1,5-a]pyridin-4-ylium hexafluorophosphate, (1.HPF6) have been described. Two novel isoelectronic and isostructural complexes, viz. [Pt(1)Cl2](2), [Au(1)Cl2][AuCl4] (3), have been synthesized and characterized by a series of spectroscopic techniques. Finally, the square planar geometry of 3 was established by single crystal X-ray diffraction studies. Interestingly, complex 3 possesses Cl--Cl interactions and this is the first organogold bears the same. Molecular docking analysis revealed the highest free binding energy for complex 3 with Human-DNA Topoisomerase. Finally, invitro anticancer studies on breast cancer cell line, MDA-MB231 revealed Au(III)-NHC complex 3 is more potent than Pt(II)-NHC complex 2. therapeutic purposes. Synthesis, structure, and anticancer activities of platinum(II)- and gold(III)-N-heterocyclic carbene complexes supported by proligand 1-methyl-2-(pyridylmethyl)imidazo[1,5-a]pyridin-4-ylium hexafluorophosphate, (1.HPF6) have been described. Two novel isoelectronic and isostructural complexes, viz. [Pt(1)Cl2](2), [Au(1)Cl2][AuCl4] (3), have been synthesized and characterized by a series of spectroscopic techniques. Finally, the square planar geometry of 3 was established by single crystal X-ray diffraction studies. Interestingly, complex 3 possesses Cl--Cl interactions and this is the first organogold bears the same. Molecular docking analysis revealed the highest free binding energy for complex 3 with Human-DNA Topoisomerase. Finally, invitro anticancer studies on breast cancer cell line, MDA-MB231 revealed Au(III)-NHC complex 3 is more potent than Pt(II)-NHC complex 2.

Organometallic Gold(III) Complexes Similar to Tetrahydroisoquinoline Induce ER-Stress-Mediated Apoptosis and Pro-Death Autophagy in A549 Cancer Cells.

A Dinuclear Cyclometalated Gold(iii)–phosphine Complex Targeting Thioredoxin Reductase Inhibits Hepatocellular Carcinoma in Vivo

Mitochondria-targeted Platinum(ii) Complexes Induce Apoptosis-Dependent Autophagic Cell Death Mediated by ER-stress in A549 Cancer Cells

Antitumor properties and mechanisms of mitochondria-targeted Ag(I) and Au(I) complexes containing N-heterocyclic carbenes derived from cyclophanes

A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex.

Synthesis, Characterization and Antitumor Activity of Novel Gold (III) Compounds with Cisplatin-Like Structure

Gold Nanoparticles Biosynthesized and Functionalized Using a Hydroxylated Tetraterpenoid Trigger Gene Expression Changes and Apoptosis in Cancer Cells

Mitochondria-targeted Cyclometalated Iridium (III) Complexes: Dual Induction of A549 Cells Apoptosis and Autophagy.

A Golgi-Targeted Platinum Complex Plays a Dual Role in Autophagy Regulation for Highly Efficient Cancer Therapy

Cyclometalated Gold(III) Complexes Containing N-Heterocyclic Carbene Ligands Engage Multiple Anti-Cancer Molecular Targets.

Investigating the Cytotoxic, Apoptotic, Treatment-Resistant, and Inflammatory Response Properties of a Gold(III) Complex Containing a Tetradentate Schiff Base Ligand

A New Class of Gold(I) NHC Complexes with Proapoptotic and Resensitizing Properties towards Multidrug Resistant Leukemia Cells Overexpressing BCL-2

pH-Sensitive Polymeric Nanoparticles with Gold(I) Compound Payloads Synergistically Induce Cancer Cell Death through Modulation of Autophagy

Amlexanox-modified Platinum(iv) Complex Triggers Apoptotic and Autophagic Bimodal Death of Cancer Cells.

A new gold(I) phosphine complex induces apoptosis in prostate cancer cells by increasing reactive oxygen species

Pro-oxidant response and accelerated ferroptosis caused by synergetic Au(I) release in hypercarbon-centered gold(I) cluster prodrugs

Discovery Of A Dual-Targeting Organometallic Ruthenium Complex With High Activity Inducing Early Stage Apoptosis Of Cancer Cells

New copper complexes inducing bimodal death through apoptosis and autophagy in A549 cancer cells

ChemInform Abstract: Chemical Biology of Anticancer Gold(III) and Gold(I) Complexes

A new anti-cancer strategy of damaging mitochondria by pro-apoptotic peptide functionalized gold nanoparticles.

Structure-base design to explore the anticancer efficacy of organometallic Pt(II)- and Au(III)-N-heterocyclic carbene (NHC) complexes